English | Español
Press release submission | Mar 30, 2019

BIOLINERX LTD.: Announces Successful Engraftment Data From Phase 3 GENESIS Trial for BL-8040 in Multiple Myeloma Patients
Press release submission | Mar 20, 2019

INNOVENT BIOLOGICS, INC. : Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody
Press release submission | Mar 15, 2019

AMGEN, INC.: Announces New Four-Year Outcomes Study To Examine Long-Term Effects Of Repatha® (evolocumab) In High-Risk Cardiovascular Disease (CVD) Patients Without Prior Heart Attack Or Stroke
Karen Kidd | Mar 11, 2019

New technologies can treat anxiety, depression through at-home brain stimulation
Press release submission | Mar 7, 2019

ALLERGAN, PLC: FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity
Press release submission | Feb 27, 2019

INNOVENT BIOLOGICS, INC.: First Patient Dosed in a Clinical Trial of Tyvyt® (Sintilimab injection) in Combination with IBI305 as First Line Treatment for Patients with Advanced Hepatocellular Carcinoma
Press release submission | Feb 21, 2019

AIVITA BIOMEDICAL, INC.: Completes Treatment of First Patient in Phase 2 Ovarian Cancer Trial
Press release submission | Feb 21, 2019

VRHEALTH: Breast Cancer Patients Cut Hot Flashes and Night Sweats by Half with VR-AI Therapy from VRHealth, Report Finds

Trending
+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT
+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+ Regulatory
Patient Daily | May 12, 2025

Turning Point USA founder: 'Big pharma’s lobbying of Washington DC has long allowed them to price gouge Americans'